The strong association between IDH-wildtype gliomas and upregulation of IL6 and IL6R expression suggests that the IL6 signalling may contribute to the poor prognosis of patients with wild-type IDH1, although the exact mechanism requires further research. The gene discussed is IDH1; the disease is glioma.